Therefore, there were some conflicts in judging about the SCT side effects in these trials, and it was decided to omit the hypoglycemia because it could occur due to the insulin therapy and thyroid autoimmune disorder along with T1DM without any intervention. The gene discussed is INS; the disease is type 1 diabetes mellitus.